https://stemcellsjournals.onlinelibrary.wiley.com/doi/10.1002/sctm.20-0508The key aim of this innovation apple to any population and any novel disease
Why is the research program described in the seminar an example of an integrated biosciences approach to an important health issue?
Should be 200 words
The main reason for this innovation being integrated is that it takes advantage of many different expertise across the field to make sure this technology is feasible and transferable in a real world setting.
Some examples of how they used integrated approaches are
The INCUBATOR addresses several of the shortcomings at the preclinical and the clinical stage that usually contribute to the failure of clinical translation through (a) systematic reviews of preclinical and clinical studies, (b) integrated knowledge transfer through engaging important stakeholders early on, (c) early economic evaluation to determine if a novel therapy is viable, and (d) retrospective and prospective studies to define and test ideal eligibility criteria to optimize clinical trial design. The INCuBAToR concept can be applied to any novel therapy in order to enhance the likelihood of success of clinical translation in a timely, transparent, rigorous, and evidence-based fashion.
The incubator uses the approaches stated above to …. therapy. The INCuBAToR presents a unique translational research platform that offers a comprehensive infrastructure to design translational research including expertise in trial design, knowledge synthesis, economic evaluation, and knowledge translation. It aims to facilitate and enable timely and robust evaluation of promising therapeutics to help bring effective therapeutics to patients sooner.
Using many different tools
Many different expertise
Systematic reviews
Many different stakeholders – Running an economic evaluation analysis, many different teams and use their field of expertise to make sure that this health technology is feasible and applicable in a population – in real ife
They have retrospective data (stata that already exists- databases that already exists) to summarize pieces of information.
It doesnt focus on only one disease or mechanism
Use these notes to suport the second paragraph
Who? Who were the project team members, what expertise did they contribute and what was the importance of the different disciplines that worked collaboratively to complete the project(s) described in the seminar
Should be 50 words
The different kinds of stakeholder, are
The reseracrher:
The economists
The clinicians
Patients/ parents- getting them on board to take part if this project
Nurses
Physicians
Regulatory agency
stakeholders, including patients, parents, physicians, nurses, and regulatory agencies
What potential challenges and ethical issues arose during the completion of the described research project and HOW were they overcome?